This educational activity is designed to incorporate evidence-based pathophysiology, diagnosis, and/or treatment of surgical disorders into clinical practice. Speakers will utilize their personal, institutional, and evidence-based experience to address patient health care conditions requiring clinical and surgical treatment. Speakers will also utilize departmental quality improvement data, M&M data, and patient safety data to improve outcomes of surgical disease and other aspects of surgical patients’ general health. Evidence-based data regarding the changing aspects/newer approaches to surgical disease will be analyzed, and critical issues related to surgery within the broader scope of American health care will be discussed.
Key Words: Surgery, Surgical innovation, Surgical education
- Physician
- Nurse Practitioner
- Physician Assistant
- Nurse
Participants who engage in this educational intervention will be able to:
- Identify the challenges of the current organ supply paradigm
- Raise awareness of the threats facing the organ supply
- Comprehend the potential role of xenografts to provide an unlimited source of organs
Activity Director:
Tracy S. Wang, MD, MPH
Professor
Department of Surgery
Medical College of Wisconsin-Froedtert
Speaker:
Robert A. Montgomery, MD, DPhil, FACS
H. Leon Pachter Chair and Professor of Surgery
NYU Langone Transplant Institute
In accordance with the ACCME® Standards for Integrity and Independence in Accredited Continuing Education, Standard 3, all in control of content must disclose any relevant financial relationships. The following in control of content had no relevant financial relationships to disclose.
- Tracy S. Wang, MD, MPH
The following persons in control of content disclosed the following financial relationships which were reviewed via the MCW conflict of interest mitigation process and addressed.
Name | Company | Role |
---|---|---|
Robert A. Montgomery, MD, DPhil, FACS | Care Dx | Advisory Committee |
Hansa Biopharma Lung Biotechnologies |
| |
Genzyme | Advisory Committee | |
Recombinetics | consultant | |
Sanofi-Aventis Us | Advisory Committee | |
Veloxis Pharmaceuticals | consultant | |
Indyairone | consultant |
Contact
- 1.00 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 1.00 Hours of ParticipationHours of Participation credit.